Announcement
18 Sep 2020
In September 2020, the European Union signed an Advanced Purchase Agreement (APA) with Sanofi Pasteur-GSK for acquiring doses of the company’s COVID-19 vaccine. The agreement was published in 2021.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
18 Sep 2020
Revocation date:
18 Sep 2022
Updated: 18 Sep 2020
Local operations incentive
On 18 September 2020, the EU and Sanofi-GSK signed an Advanced Purchase Agreement (APA) for the production, purchase and supply of the company’s COVID-19 vaccine. The agreement included certa...
Sign in to see more
Related State Acts
29 Jan 2021
EU: Commission adopts temporary export authorisation for COVID-19 vaccines
30 Nov 2020
EU: COVID-19 Advanced Purchase Agreement with CureVac includes localisation requirement
20 Nov 2020
EU: Localisation requirement included in the Advanced Purchase Agreement with BioNTech-Pfizer
27 Aug 2020
EU: COVID-19 Advanced Purchase Agreement with AstraZeneca includes localisation requirement
Threads
See all
This state act is not part of any Thread yet.